William Marsh Rice University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, William Marsh Rice University sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials 2 currently recruiting 4 completed upper quartile by trial count

William Marsh Rice University: 8 sponsored US clinical trials, 2 recruiting.

William Marsh Rice University sponsors 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Jaundice, Neonatal, with 1 trials.

Upper-quartile sponsor footprint

William Marsh Rice University sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

8 total, page 1 of 1

RECRUITING NA

Can the Language Environment Analysis Start Program Improve Children's Readiness for School? LENA Program Evaluation

NCT04905381
RECRUITING

Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings

NCT03866213
NOT YET RECRUITING Phase 4

Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1

NCT07554417
COMPLETED NA

Cognitive Health Research on Musical Arts

NCT04137913
TERMINATED NA

Evaluation Study of the Impact of the New Brain Builders Parenting Class

NCT03866616
COMPLETED NA

Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Pregnant Women

NCT02319174
COMPLETED NA

Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers

NCT02267577
COMPLETED Phase 1

AAN Robotic Therapy in SCI

NCT02803255

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Therapeutic Areas

Jaundice, Neonatal 1
Hyperbilirubinemia, Neonatal 1

What is open in the William Marsh Rice University pipeline

2 recruiting of 8 indexed (25% open); 4 completed (50%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Jaundice, Neonatal (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

William Marsh Rice University: open-pipeline peers nationwide

Peers matched on 8 registered trials and 25% open enrollment, not the therapeutic-area sidebar.

William Marsh Rice University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 3456789 0%10%20%30%40% Total trials Recruiting share William Marsh Rice UniversityAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Abdul Latif Jameel Poverty Action LabAccutar BiotechnologyAdrienne G. WaksAdvocate Hospital System
William Marsh Rice University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

William Marsh Rice University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 trials (± recruiting share)

Sponsors near 25% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this William Marsh Rice University page

8 registered trials is a research-attention snapshot, not an endorsement of William Marsh Rice University or any single study.

  • 2 of William Marsh Rice University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Jaundice, Neonatal is the condition William Marsh Rice University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Jaundice, Neonatal trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

William Marsh Rice University pipeline card: 8 registered trials from official public datasets.Report a data error.